Privia Health Group Inc (PRVA) Shares Decline Despite Market Challenges

The stock price of Privia Health Group Inc (NASDAQ: PRVA) has plunged by -4.79 when compared to previous closing price of 19.01, but the company has seen a -5.19% decline in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-02-27 that Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Is It Worth Investing in Privia Health Group Inc (NASDAQ: PRVA) Right Now?

Privia Health Group Inc (NASDAQ: PRVA) has a higher price-to-earnings ratio of 97.73x compared to its average ratio, The 36-month beta value for PRVA is at 0.81. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


The public float for PRVA is 101.95M, and currently, shorts hold a 7.16% of that float. The average trading volume for PRVA on April 03, 2024 was 984.07K shares.

PRVA’s Market Performance

PRVA’s stock has seen a -5.19% decrease for the week, with a -18.91% drop in the past month and a -21.41% fall in the past quarter. The volatility ratio for the week is 4.49%, and the volatility levels for the past 30 days are at 4.33% for Privia Health Group Inc The simple moving average for the past 20 days is -12.35% for PRVA’s stock, with a -21.82% simple moving average for the past 200 days.

Analysts’ Opinion of PRVA

Many brokerage firms have already submitted their reports for PRVA stocks, with Barclays repeating the rating for PRVA by listing it as a “Equal Weight.” The predicted price for PRVA in the upcoming period, according to Barclays is $22 based on the research report published on March 06, 2024 of the current year 2024.

Jefferies, on the other hand, stated in their research note that they expect to see PRVA reach a price target of $25, previously predicting the price at $33. The rating they have provided for PRVA stocks is “Buy” according to the report published on February 26th, 2024.

BofA Securities gave a rating of “Neutral” to PRVA, setting the target price at $21 in the report published on February 22nd of the current year.

PRVA Trading at -13.36% from the 50-Day Moving Average

After a stumble in the market that brought PRVA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -39.97% of loss for the given period.

Volatility was left at 4.33%, however, over the last 30 days, the volatility rate increased by 4.49%, as shares sank -17.28% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -13.11% lower at present.

During the last 5 trading sessions, PRVA fell by -5.19%, which changed the moving average for the period of 200-days by -35.01% in comparison to the 20-day moving average, which settled at $20.46. In addition, Privia Health Group Inc saw -21.41% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at PRVA starting from Sullivan William M, who sale 400 shares at the price of $23.02 back on Mar 11 ’24. After this action, Sullivan William M now owns 5,445,018 shares of Privia Health Group Inc, valued at $9,208 using the latest closing price.

Sullivan William M, the Director of Privia Health Group Inc, sale 7,115 shares at $23.03 during a trade that took place back on Mar 08 ’24, which means that Sullivan William M is holding 5,445,418 shares at $163,858 based on the most recent closing price.

Stock Fundamentals for PRVA

Current profitability levels for the company are sitting at:

  • 0.01 for the present operating margin
  • 0.1 for the gross margin

The net margin for Privia Health Group Inc stands at 0.01. The total capital return value is set at 0.03. Equity return is now at value 4.35, with 2.55 for asset returns.

Based on Privia Health Group Inc (PRVA), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at 10.13. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is -0.01.

Currently, EBITDA for the company is 27.18 million with net debt to EBITDA at -14.02. When we switch over and look at the enterprise to sales, we see a ratio of 1.06. The receivables turnover for the company is 5.7for trailing twelve months and the total asset turnover is 1.66. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.81.


In conclusion, Privia Health Group Inc (PRVA) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts